Fundraising FoxGlobal BioAccess Fund — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Nuvig Therapeutics is a biotech company developing immune-modulating therapies for autoimmune and chronic inflammatory diseases, using an endogenous regulatory mechanism intended to treat inflammation without compromising broader immune function.
BiotechLongevity
Co-investorsSanofi Venturesabrdn plcAlexandriaB CapitalDigitalis VenturesLeaps by Bayer+4 more
ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.
BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US
Robert Binney(Executive Officer, Director)
BoardJoyce Erony(Director)inZack Scott(Director)inBrad Vale(Director)inCasey Tansey(Director)Mudit Jain(Executive Officer, Director)in
Co-investorsAmzak HealthAPERTURE Venture PartnersBreakout VenturesNorwest Venture PartnersOSF VenturesSeroba Life Sciences+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.